Progress on COVID-19 vaccine development programs

Progress on COVID-19 vaccine development programs

Monday, November 2, 2020 4:40 PM to 5:25 PM · 45 min. (Africa/Abidjan)

World Immunotherapy Congress

Keynote sessions: Immunotherapy

Panel discussion

Information

Moderator: Hannah Kuchler, US Pharma and Biotech Correspondent, Financial Times

Panellists:

Farshad Guirakhoo, Chief Scientific Officer, COVAXX
Hanneke Schuitemaker, VP, Viral Vaccine Discovery and Translational Medicine, Janssen
Josh Morrison, Co-Founder and Executive Director, 1Day Sooner
Kate Broderick, VP Research and Development, Inovio

Bio-TechneBio-Techne® unites some of the most referenced brands in Life Sciences: R&D Systems®, Novus Biologicals®, Tocris Bioscience ®, ProteinSimple® and Advanced Cell Diagnostics®. Our family of brands collaborate to provide over 350,000 products for Life Science research. We have over 300,000 journal citations, showing that our combined experience is trusted by researchers. We are passionate about scientific discovery, which drives us to manufacture high-quality reagents and award-winning tools for the Life Science and Clinical Diagnostic markets. We understand our customers and we really care about their research. To ensure researcher’s experiments are successful, we provide the reliable high-performance innovative solutions they require for scientific discovery.

Log in

See all the content and easy-to-use features by logging in